Literature DB >> 16917756

Diabetes and brain damage: more (or less) than meets the eye?

Christopher M Ryan1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16917756     DOI： 10.1007/s00125-006-0392-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  41 in total

1.  Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury.

Authors:  Sari Mäkimattila; Kirsi Malmberg-Cèder; Anna-Maija Häkkinen; Kim Vuori; Oili Salonen; Paula Summanen; Hannele Yki-Järvinen; Markku Kaste; Sami Heikkinen; Nina Lundbom; Risto O Roine
Journal:  J Cereb Blood Flow Metab       Date:  2004-12       Impact factor: 6.200

Review 2.  Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality.

Authors:  T Y Wong; R Klein; B E Klein; J M Tielsch; L Hubbard; F J Nieto
Journal:  Surv Ophthalmol       Date:  2001 Jul-Aug       Impact factor: 6.048

3.  Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.

Authors:  Alette M Wessels; Serge A R B Rombouts; Suat Simsek; Joost P A Kuijer; Piet J Kostense; Frederik Barkhof; Philip Scheltens; Frank J Snoek; Robert J Heine
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

4.  Reduced cerebral blood flow response and compensation among patients with untreated hypertension.

Authors:  J R Jennings; M F Muldoon; C Ryan; J C Price; P Greer; K Sutton-Tyrrell; F M van der Veen; C C Meltzer
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

Review 5.  Hypoglycemic brain damage.

Authors:  Roland N Auer
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

Review 7.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature.

Authors:  Jack C de la Torre
Journal:  Neurol Res       Date:  2004-07       Impact factor: 2.448

8.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

9.  Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications.

Authors:  C M Ryan; M O Geckle; T J Orchard
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

10.  Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

Authors:  Oda-Christina Suter; Thanomphone Sunthorn; Rudolf Kraftsik; Joel Straubel; Pushpa Darekar; Kamel Khalili; Judith Miklossy
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914
View more
  11 in total

1.  Diabetes, cognitive impairment, and dementia.

Authors:  Mark W J Strachan; Jacqueline F Price; Brian M Frier
Journal:  BMJ       Date:  2008-01-05

Review 2.  Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain.

Authors:  Ana Maria Arbelaez; Katherine Semenkovich; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2013-10-14       Impact factor: 4.866

3.  Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited.

Authors:  B M Frier
Journal:  Diabetologia       Date:  2010-11-26       Impact factor: 10.122

4.  The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort.

Authors:  A M Jacobson; A D Paterson; C M Ryan; P A Cleary; B H Waberski; K Weinger; G Musen; W Dahms; M Bayless; N Silvers; J Harth; A P Boright
Journal:  Diabet Med       Date:  2010-01       Impact factor: 4.359

5.  Association of Depression With Functional Mobility in Schizophrenia.

Authors:  Jiheon Kim; Ji-Hyeon Shin; Jeh-Kwang Ryu; Jae Hoon Jung; Chan-Hyung Kim; Hwa-Bock Lee; Do Hoon Kim; Sang-Kyu Lee; Daeyoung Roh
Journal:  Front Psychiatry       Date:  2020-08-21       Impact factor: 4.157

6.  Neurovascular Organotypic Culture Models Using Induced Pluripotent Stem Cells to Assess Adverse Chemical Exposure Outcomes.

Authors:  Eric H Nguyen; Micah J Dombroe; Debra L Fisk; William T Daly; Christine M Sorenson; William L Murphy; Nader Sheibani
Journal:  Appl In Vitro Toxicol       Date:  2019-06-17

Review 7.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

Review 8.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

9.  Long-term effect of diabetes and its treatment on cognitive function.

Authors:  Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

10.  Astroglial pentose phosphate pathway rates in response to high-glucose environments.

Authors:  Shinichi Takahashi; Yoshikane Izawa; Norihiro Suzuki
Journal:  ASN Neuro       Date:  2012-03-22       Impact factor: 4.146
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.